News & Updates
Filter by Specialty:
High BMI might promote MGUS progression to multiple myeloma
In individuals with monoclonal gammopathy of undetermined significance (MGUS), obesity or high body mass index (BMI) seems to aggravate the risk of disease progression to multiple myeloma (MM), an effect that appears to be stronger in women, a recent study has found.
High BMI might promote MGUS progression to multiple myeloma
17 May 2022
Modern radiotherapy safe for heart in breast cancer patients
Breast cancer patients see no excess risk of ischaemic heart disease (IHD)-related mortality after radiotherapy (RT) treatment, according to a recent Singapore study.
Modern radiotherapy safe for heart in breast cancer patients
17 May 2022
Add-on ixazomib does not improve cyclophosphamide-dexamethasone combo in frail MM patients
The addition of ixazomib to cyclophosphamide-dexamethasone treatment does not seem to result in better survival and response rates in patients with newly diagnosed and relapsed multiple myeloma (MM), a recent study has found.
Add-on ixazomib does not improve cyclophosphamide-dexamethasone combo in frail MM patients
17 May 2022
Chamomile improves skin recovery in breast cancer patients with radiodermatitis
A topical formulation containing chitosan-coated Chamomilla recutita (L.) rauschert microparticles does not lower any grade of radiodermatitis (RD) but is effective in reducing grade ≥2 toxicity to improve skin recovery and diminish high-intensity local symptoms in women with breast cancer, a study has shown.